Not available
Quote | XOMA Corporation (NASDAQ:XOMA)
Last: | $28.59 |
---|---|
Change Percent: | -0.64% |
Open: | $28.24 |
Close: | $28.59 |
High: | $28.6499 |
Low: | $27.67 |
Volume: | 11,299 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | XOMA Corporation (NASDAQ:XOMA)
2024-07-19 08:30:00 ET Summary Royalty interests present a lucrative opportunity for passive income from the popularity and demand for certain goods. Get paid on autopilot via public companies that manage a portfolio of royalty interests and distribute the proceeds to shareholders...
2024-07-05 16:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | XOMA Corporation (NASDAQ:XOMA)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $XOMA News Article - XOMA to Present at H.C. Wainwright BioConnect Investor Conference | whytestocks | investorshangout | 04/26/2023 7:45:48 PM |
Keeps going up ????? | ison929 | investorshub | 07/15/2022 3:18:04 PM |
Up | highstakes | investorshub | 06/08/2022 11:45:48 AM |
whytestocks: $XOMA News Article - Kuros Biosciences: Completion of the Acquisition of Checkmate Phar | whytestocks | investorshangout | 06/02/2022 2:35:50 PM |
https://abcnews.go.com/Health/antibody-therapies-cut-deaths-reduce-exposure-covi | Preciouslife1 | investorshub | 01/28/2021 1:37:10 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-05 16:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has received an $8.1 million milestone payment from Viracta Therapeutics, Inc., related to Day One Biopharmaceuticals’ recent sale of its Priority Revie...
2024-06-04 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...